Jessie Janeczek, VP of Global Sales, reflects on how research partnerships have shaped Transnetyx services and what it means to keep listening as laboratory needs change.
Serving Research & Saving Time
Jessie Janeczek, VP of Global Sales
One thing that has never changed about Transnetyx is our commitment to saving laboratories a significant amount of time to dedicate to science. Twenty-six years ago, we did this through Automated Genotyping — researchers could eliminate the redundancies and transcription errors of the gel-based PCR process and recover multiple days, sometimes even months, of time. As the years passed, we recognized a new challenge: significant delays in research are often caused by labs and animal programs having to operate across multiple, disconnected systems — sometimes just to log the simplest data, like animal research purpose or cage census. With our focus on saving time, we now offer multiple diagnostic service sets alongside colony management platforms. This has never been about "selling more stuff" or "expanding a portfolio." Our mission has always been, and will continue to be, making diagnostics and data capture fast and easy for labs, so they can focus on what matters most: research that leads to great discovery. The sales team at Transnetyx remains committed to being good stewards of your time and your research, working alongside labs as a true consultative partner.
What Institutional Partnerships Have Taught Us
Research is an ever-evolving ecosystem, and that is exactly how I view the commercial team at Transnetyx. We constantly ask questions like, are we meeting our customers' expectations? What can we do better? Where do we not have enough in-field support? Are there new and emerging technologies our labs need to be successful that we're not yet aware of? And here is what makes us unique: we listen. When I was hired 14 years ago, I could hold our Sales team in the palm of my hand. We now have over 30 commercial individuals serving your research. In addition to adding people, we can say with certainty that every service set we've expanded into, and every piece of software we've developed or acquired, is grounded in direct customer feedback that it addresses a gap that they need filled. Two simple, telling examples are Colony + AMI and Genetic Monitoring. We originally built Colony alongside UCSF to make sure we were creating a colony management platform that was enjoyable — and easy — to use. Working closely with UCSF gave us two distinct perspectives: one from the animal program and one from the research labs themselves. Needless to say, it is a very well adopted software now! Genetic Monitoring grew out of a core partnership at UNC. We had the opportunity to become the single distributor of miniMUGA technology, and since then we've helped multiple leading research institutions launch Genetic Integrity Programs, where animal backgrounds are checked upon import for new lines or before new projects begin. As funding grew tighter, we also worked closely with institutions like Vanderbilt to build our services directly into per diems, so researchers continue to have the services they need without additional budget hurdles. None of these innovations could have happened in isolation. It's through earning trust and building lasting partnerships that we've been able to serve the research community well, and it's work we're proud of.
A Changing Research Landscape
That same partnership mindset is what will carry us into the next chapter of research — because the ground under our customers is shifting again. The NIH's recent creation of the Office of Research Innovation, Validation, and Application (ORIVA) signals a real inflection point: a coordinated push to accelerate human-based research methods —while gradually shifting funding away from traditional animal studies. For our customers, this doesn't mean animal research disappears overnight. It means the bar for how that research is designed, justified, and reported is rising. Grant reviewers and funding bodies will increasingly ask what a given model system actually tells us about human biology, and what resources it requires to get there.
A Consultative Role For What Comes Next
This is where I believe our sales organization must keep evolving, not by chasing every new technology trend, but by getting closer to the specific moment each lab is in. Reduction depends on knowing genotypes early and confidently, catching genetic drift before it compounds, and breeding only what the science actually calls for — which is exactly why our reps need to understand your lab as well as they understand our own services. Refinement depends on clean, centralized data flowing to the people who need it, which is why platforms like tick@lab and Colony + AMI aren't side projects; they're becoming as central to our conversations as genotyping itself. As the industry continues shifting in this new direction, our team's job shifts further from "vendor" to "advisor" — someone who can sit with a PI or a vivarium manager and map out how diagnostics, colony data, and lab automation fit together under one roof, rather than selling any one piece in isolation.
Twenty-six years ago, the problem was gel-based PCR eating up a researcher's week. Today, it's fragmented systems, tightening budgets, and a funding landscape in transition. Tomorrow, it will be something we do not even know about yet. What won't change is our approach: listen first, build in partnership with the institutions doing the work, and let the sales team's evolution be driven by what labs actually need. We are thankful for the continued opportunity to serve your research!
Meet the Transnetyx team at AALAS 2026 to discuss the needs and handoffs shaping your laboratory.
